Agios Pharmaceuticals, Inc. (AGIO)
26.85
-0.43
(-1.58%)
USD |
NASDAQ |
Dec 09, 16:00
26.92
+0.07
(+0.26%)
After-Hours: 05:10
Agios Pharmaceuticals Total Liabilities (Quarterly): 101.38M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Fulcrum Therapeutics, Inc. | 16.49M |
| Moderna, Inc. | 2.805B |
| EyePoint Pharmaceuticals, Inc. | 51.51M |
| Vanda Pharmaceuticals, Inc. | 135.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.386B |
| Shareholders Equity (Quarterly) | 1.284B |
| Debt to Equity Ratio | 0.0347 |
| Current Ratio | 13.82 |
| Net Debt Paydown Yield | 0.17% |